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RESUMO
As infeções pelo vírus da hepatite E do genótipo 3 são normalmente assintomáticas em indivíduos imunocompetentes. Os casos 
sintomáticos de hepatite E aguda ictérica são raramente observados em mulheres, crianças e jovens adultos, sendo mais frequentes 
em homens de meia-idade e idosos. Descrevemos um caso de hepatite aguda severa com hospitalização prolongada numa mulher 
imunocompetente de 40 anos causada pelo vírus da hepatite E do genótipo 3. Da sua história clínica destacavam-se doenças autoi-
munes, nomeadamente gastrite atrófica e doença de Graves. A mulher apresentava uma necrose hepática grave, revelada pelos 
altos níveis de aminotransferases (ALT 4893 U/L; AST 3138 U/L), e distúrbios de coagulação (tempo de protrombina; INR = 1,33). Os 
marcadores serológicos para os vírus das hepatites A, B e C foram negativos; a pesquisa de ARN do vírus da hepatite E foi positiva no 
soro. A sequenciação e a análise filogenética revelaram que o vírus da hepatite E em causa pertencia ao subgenótipo 3a. Os autores 
sugerem uma associação entre a infeção aguda severa causada pelo vírus da hepatite E genótipo 3 e o historial autoimune da mulher.
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ABSTRACT
Hepatitis E virus genotype 3 infections are normally asymptomatic in immunocompetent individuals. Symptomatic cases of acute 
icteric hepatitis E are seldom observed among women, younger men and children but are particularly seen in middle-aged/elderly 
men. We report a case of severe acute hepatitis E caused by genotype 3 in an immunocompetent 40-year-old woman that required 
prolonged hospitalization. Her medical history included an autoimmune background, namely atrophic gastritis and Graves’ disease. 
She presented an extensive hepatic necrosis as revealed by the high levels of aminotransferases (ALT 4893 U/L; AST 3138 U/L). She 
showed also a coagulation disorder (prothrombin time; INR = 1.33). Serological markers for hepatitis viruses A, B and C were nega-
tive but serum was positive for hepatitis E virus RNA. Sequencing and phylogenetic analysis revealed that the hepatitis E virus strain 
belonged to subgenotype 3a. This is suggestive of an association between the severe acute hepatitis E virus genotype 3 infection and 
the autoimmune background.
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INTRODUCTION
 More than ten years have passed since the first reports 
of autochthonous hepatitis E virus (HEV) infections in high-
-income countries but viral pathogenesis and clinical as-
pects remain to be clarified concerning HEV genotype 3, 
the one responsible for the majority of the locally-acquired 
(autochthonous) cases in Europe and in many other indus-
trialized countries.1,2 It is now known that autochthonous 
HEV genotype 3 infections are very common in these coun-
tries, based on several studies reporting high HEV sero-
prevalence rates.1,2 Despite this, hepatitis E in high-income 
countries remains undetected or undiagnosed.3 Moreover, 
in Europe both the number of autochthonous HEV infec-
tions as well as the number of HEV-related hospitalisations 
has been increasing in the last decade.4 Food is the major 
route of transmission of HEV genotype 3 in Europe, with 
consumption of raw (or under-cooked) pig and wild boar 
meat products being the main source of infection. But other 
foods have been suspected as well.5
In Portugal, the presence of HEV in humans, animals 
and the environment has been described during the past 
years. Reports of autochthonous cases of hepatitis E with 
distinct clinical presentations that varied from neurological 
complications, to chronic presentations and autoimmune 
disorders were documented.6–9 Moreover, epidemiologi-
cal studies have demonstrated the presence of antibodies 
against HEV in the Portuguese population of all ages, from 
a wide array of settings and throughout the country,10–14 con-
firming that HEV is endemic in Portugal.14 Moreover, molec-
ular studies in pigs and wild boar revealed the presence and 
circulation of HEV genotype 3 in these animals throughout 
the national territory.15–17 HEV genotype 3 has also been 
detected in wastewater from treatment plants in Portugal.18
Infections with HEV genotype 3 are typically self-limit-
ed and asymptomatic in immunocompetent individuals.3 
Symptomatic cases of acute icteric hepatitis occur markedly 
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younger men and children.1,19,20 One of the most curious 
aspects of HEV genotype 3 infection is the association with 
numerous extra-hepatic manifestations that may develop 
either in acute or chronic infections. However, the role of 
genotype 3 in these disorders is yet to be clarified, including 
the autoimmune extra-hepatic manifestations.21 
The present study reports a case of severe acute hep-
atitis E caused by genotype 3 in an immunocompetent 
40-year-old woman with a medical history of autoimmune 
disorders that required hospitalization for 14 days. 
CASE REPORT
On the 15th December 2015, a 40-year-old woman pre-
sented with exuberant jaundice to the Emergency Unit of 
a Hospital in Lisbon, Portugal. One week before, she had 
started with nausea, abdominal pain, having dark urine 
and pale colored stools. She had no history of drug use 
or sexual risk behavior, occupational risk to HBV or HCV, 
household contact with a person with hepatitis A, travel 
to endemic areas of hepatitis A or E. She denied contact 
with animals and consumption of herbal products, wild 
mushrooms or recent introduction of pharmaceuticals 
(antibiotics, anti-inflammatory drugs and analgesics). Her 
medical history included autoimmune disorders, namely 
autoimmune atrophic gastritis and Graves’ disease, in 
remission. Abdominal ultrasonography and radiography 
showed no changes, and electrocardiography was normal 
as well. Blood tests revealed a coagulation disorder (pro-
thrombin time; INR = 1.33). The normal level of ceruloplas-
min excluded Wilson’s disease. Antinuclear auto-antibodies 
(ANA) were only slightly positive (titer 1:160) but all other 
autoimmune markers were negative. Liver function tests 
(Table 1) showed a marked elevation of hepatic enzymes 
with alanine aminotransferase (ALT) values higher than 
aspartate aminotransferase (AST) (4893 IU/L versus 3138 
IU/L, respectively) a pattern suggestive of viral hepati-
tis. Serological markers of acute infection for hepatitis A, 
B and C viruses, Epstein-Barr virus and cytomegalovirus 
were all negative. She also tested negative for Coxiella 
burnetii and Rickettsia. Since the patient’s history was not 
suspicious for hepatitis E, antibodies anti-HEV IgM and IgG 
were not searched for. HEV RNA was only later detected 
(after discharge) in archived serum collected on admis-
sion. Real-time reverse transcription PCR (RT-PCR) with 
Figure 1 – Phylogenetic tree based on partial RNA-dependent RNA-polymerase region of open reading frame 1 (330 bp) using neighbor-
joining method based on the Jukes-Cantor model and 1000 bootstrap resamplings. PoHuG32016HEV represents the sequence charac-
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primers/probe targeting the open reading frame (ORF) 2 
region22 was used for HEV RNA detection. For the genetic 
characterization of the HEV strain, a 330 nucleotide partial 
sequence in ORF 1 region was amplified with nested broad-
spectrum RT-PCR.23 The phylogenetic analysis indicated 
that the sequence retrieved from the woman clustered with 
HEV genotype 3, subgenotype 3a sequences (Fig. 1). 
The clinical evolution of the woman was favorable and 
she was discharged on the 29th December, 14 days after 
admission. At discharge, prothrombin time was already 
normal (INR = 0.97) and bilirubin and transaminases were 
decreasing showing almost normal values on the follow-up 
analysis of 25th January (Table 1).
DISCUSSION
The present report describes a case of autochthonous 
severe acute hepatitis E caused by genotype 3 in a 40 year 
old woman with an autoimmune background. Although 
acute icteric hepatitis caused by HEV genotype 3 is mainly 
observed among men aged over 60, this middle-aged wom-
an developed a severe hepatitis with an extensive hepatic 
necrosis as revealed by the high levels of aminotransferases 
(> 3000 UI/L) that required 14 days of hospitalization. Cases 
of acute hepatitis E have been described in women asso-
ciated with concomitant signs of autoimmunity9,24 and also 
with signs of hyperthyroidism (including Grave´s disease), 
subclinical hyperthyroidism and subacute thyroiditis.25–28 In 
the present case, the woman’s severe clinical course was 
only accompanied by a slightly positive ANA titer while the 
other autoimmune markers were absent, which ruled out 
an autoimmune hepatitis. Bearing in mind that the medical 
history of this patient included Graves’ disease (although 
in remission), liver dysfunction (causing severe icteric hep-
atitis) in a context of hyperthyroidism due to a relapse of 
Graves disease cannot be excluded. Unfortunately, thyroid 
hormone levels (T3, T4 and TSH) were not investigated in 
the patient. It would be interesting to check the levels of thy-
roid hormones since liver dysfunction has been observed 
in patients with hyperthyroidism ranging from mild liver test 
abnormalities to deep jaundice.29
It seems very unlikely that HEV genotype 3 had been the 
sole responsible for the exuberant clinical manifestations 
since this genotype is rarely associated with severe disease 
in healthy women. The pathogenesis of HEV infection is 
still unclear and involves a complex interplay between the 
virus and its host, particularly the host immune system.30 So 
we hypothesize that the patient’s autoimmune background 
could have been a contributing factor for  severe hepatitis 
E. However, since no ANA or other autoimmune markers 
were screened for upon discharge or during follow-up, a 
definitive association between the course of hepatitis E and 
autoimmunity cannot be established. Nonetheless, such an 
association has been documented in a previous case report 
from Portugal.9 
In conclusion, the present clinical case highlights the 
need to include HEV (along with HAV, HBV and HCV) in 
the differential diagnosis of patients presenting acute hepa-
tocellular damage in industrialized countries, regardless of 
travel history, as autochthonous HEV infections have been 
increasing in high-income countries. 
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Table 1 – Laboratory parameters on admission and at discharge (14 days of hospitalization)




(January 25) Reference values
Haemoglobin (g/dL) 14.4 13.4 ND 12 – 15.6
Leukocytes (x109/L) 6.6 5.2 ND 4.5 – 11.0
PT (INR) 1.33 0.97 ND ≤ 1.1
AST (U/L) 3138 131 49 5.0 – 34.0
ALT (U/L) 4893 299 81 0.0 – 55.0
GGT (U/L) 89 61 51 9.0 – 36.0
Total BIL (mg/dL) 19 15.57 2.33 0.2 – 1.2
Direct BIL (mg/dL) 14 10.15 1.37 0.0 – 0.50
LDH (IU/L) 832 168 ND 125 – 220
ALP (U/L) 158 118 ND 37 – 98
PT: prothrombin time; AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT: gamma-glutamyl transpeptidase; BIL: bilirubin; LDH: lactate 
dehydrogenase; ALP: alkaline phosphatase. 
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